BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21774748)

  • 1. Synthesis and structure-activity relationship of novel conformationally restricted analogues of serotonin as 5-HT6 receptor ligands.
    Nirogi RV; Kambhampati R; Kothmirkar P; Konda J; Bandyala TR; Gudla P; Arepalli S; Gangadasari NP; Shinde AK; Deshpande AD; Dwarampudi A; Chindhe AK; Dubey PK
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):443-50. PubMed ID: 21774748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.
    Nirogi R; Dwarampudi A; Kambhampati R; Bhatta V; Kota L; Shinde A; Badange R; Jayarajan P; Bhyrapuneni G; Dubey PK
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4577-80. PubMed ID: 21724392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6 receptor ligands.
    Nirogia RV; Kambhampati R; Daulatabad AV; Gudla P; Shaikh M; Achanta PK; Shinde AK; Dubey PK
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):341-9. PubMed ID: 21524149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT(6) receptor antagonists.
    Nirogi RV; Daulatabad AV; Parandhama G; Mohammad S; Sastri KR; Shinde AK; Dubey PK
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4440-3. PubMed ID: 20594839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands.
    Nirogi RV; Badange R; Kambhampati R; Chindhe A; Deshpande AD; Tiriveedhi V; Kandikere V; Muddana N; Abraham R; Khagga M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7431-5. PubMed ID: 23141912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands.
    Chang-Fong J; Rangisetty JB; Dukat M; Setola V; Raffay T; Roth B; Glennon RA
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1961-4. PubMed ID: 15050637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
    J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV; Deshpande AD; Kambhampati R; Badange RK; Kota L; Daulatabad AV; Shinde AK; Ahmad I; Kandikere V; Jayarajan P; Dubey PK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):346-9. PubMed ID: 21134749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia.
    Johnson CN; Ahmed M; Miller ND
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):642-54. PubMed ID: 18729016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation.
    Dukat M; Smith C; Herrick-Davis K; Teitler M; Glennon RA
    Bioorg Med Chem; 2004 May; 12(10):2545-52. PubMed ID: 15110837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3929-31. PubMed ID: 18583130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism.
    Harris RN; Stabler RS; Repke DB; Kress JM; Walker KA; Martin RS; Brothers JM; Ilnicka M; Lee SW; Mirzadegan T
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3436-40. PubMed ID: 20434910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
    Haydar SN; Yun H; Andrae PM; Mattes J; Zhang J; Kramer A; Smith DL; Huselton C; Graf R; Aschmies S; Schechter LE; Comery TA; Robichaud AJ
    J Med Chem; 2010 Mar; 53(6):2521-7. PubMed ID: 20170099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands.
    Lee M; Rangisetty JB; Pullagurla MR; Dukat M; Setola V; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1707-11. PubMed ID: 15745826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F; Cho S; Rhim H; Indu Viswanath AN; Pae AN; Lee JY; Choo DJ; Choo HY
    Bioorg Med Chem; 2013 Sep; 21(17):5573-82. PubMed ID: 23810425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands.
    Alcalde E; Mesquida N; Frigola J; López-Pérez S; Mercè R
    Org Biomol Chem; 2008 Oct; 6(20):3795-810. PubMed ID: 18843410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.